- Obesity-linked conditions are projected to rise sharply in children
- Stem cells from jaw bone help repair damaged cartilage
- Significant survival gains from neoadjuvant chemotherapy for high-risk soft tissue sarcoma
- Nintedanib improves progression-free survival but not overall survival in phase III trial of metastatic colorectal cancer
- Nivolumab maintains function, reduces symptoms in treatment of relapsed metastatic head and neck cancer
- Ipilimumab as adjuvant therapy improves overall survival in high risk stage III melanoma
- Mystery of bacteria’s antibiotic resistance unravelled
- Study supports do not sell voluntary waiting period for gun sales to reduce suicide
- Are natural alternatives to estrogen replacement therapy safe?
- Cortisol-free rheumatoid arthritis medication also works for rare eye disease
- Cabozantinib improves progression-free survival in metastatic renal cell carcinoma
- Ceritinib provides longer progression-free survival than chemotherapy in phase III trial of ALK rearranged lung cancer treatment
- Significant survival gains with atezolizumab vs docetaxel for non-small-cell lung cancer
- Immunotherapy shows promising results in first, second line treatment of metastatic bladder cancer
- African-American, Hispanic men less likely to get treatment for prostate cancer, even with high-risk disease
- What’s really going on in PTSD brains? Experts suggest new theory
- Significant cost differences found between breast cancer chemotherapy regimens
- Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer
- First-line pembrolizumab plus chemotherapy significantly improves outcomes in advanced NSCLC
- Pembrolizumab new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression
- Targeting estrogen receptor improves progression-free survival in advanced breast cancer
- Kids’ consumption of high-calorie drinks at fast-food restaurants tied to combo meals
- UK’s approach to health needs radical rethinking, experts say
- Research uncovers a new disruption at the root of Parkinson’s disease